Table of Contents

1 Study Coverage

• 1.1 Fibrin Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Fibrin Market Size Growth Rate by Product
  • 1.4.2 Human Fibrinogen Concentrate
  • 1.4.3 Animal Fibrinogen Concentrate
• 1.5 Market by End User
  • 1.5.1 Global Fibrin Market Size Growth Rate by End User
  • 1.5.2 Trauma patients
  • 1.5.3 Cardiovascular surgery patients
  • 1.5.4 PPH patients
  • 1.5.5 Plastic surgery patients
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Fibrin Market Size
  • 2.1.1 Global Fibrin Revenue 2014-2025
  • 2.1.2 Global Fibrin Sales 2014-2025
• 2.2 Fibrin Growth Rate by Regions
  • 2.2.1 Global Fibrin Sales by Regions
  • 2.2.2 Global Fibrin Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Fibrin Sales by Manufacturers
  • 3.1.1 Fibrin Sales by Manufacturers
  • 3.1.2 Fibrin Sales Market Share by Manufacturers
  • 3.1.3 Global Fibrin Market Concentration Ratio (CR5 and HHI)
• 3.2 Fibrin Revenue by Manufacturers
  • 3.2.1 Fibrin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Fibrin Revenue Share by Manufacturers (2014-2019)
• 3.3 Fibrin Price by Manufacturers
• 3.4 Fibrin Manufacturing Base Distribution, Product Types
  • 3.4.1 Fibrin Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Fibrin Product Type
  • 3.4.3 Date of International Manufacturers Enter into Fibrin Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Fibrin Sales by Product
• 4.2 Global Fibrin Revenue by Product
• 4.3 Fibrin Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Fibrin Breakdown Data by End User

6 North America

• 6.1 North America Fibrin by Countries
  • 6.1.1 North America Fibrin Sales by Countries
  • 6.1.2 North America Fibrin Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Fibrin by Product
• 6.3 North America Fibrin by End User

7 Europe

• 7.1 Europe Fibrin by Countries
  • 7.1.1 Europe Fibrin Sales by Countries
  • 7.1.2 Europe Fibrin Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Fibrin by Product
• 7.3 Europe Fibrin by End User

8 Asia Pacific

• 8.1 Asia Pacific Fibrin by Countries
  • 8.1.1 Asia Pacific Fibrin Sales by Countries
  • 8.1.2 Asia Pacific Fibrin Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Fibrin by Product
• 8.3 Asia Pacific Fibrin by End User

9 Central & South America

• 9.1 Central & South America Fibrin by Countries
  • 9.1.1 Central & South America Fibrin Sales by Countries
  • 9.1.2 Central & South America Fibrin Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Fibrin by Product
• 9.3 Central & South America Fibrin by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Fibrin by Countries
  • 10.1.1 Middle East and Africa Fibrin Sales by Countries
  • 10.1.2 Middle East and Africa Fibrin Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Fibrin by Product
• 10.3 Middle East and Africa Fibrin by End User

11 Company Profiles

• 11.1 CSL Behring
  • 11.1.1 CSL Behring Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 CSL Behring Fibrin Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 CSL Behring Fibrin Products Offered
  • 11.1.5 CSL Behring Recent Development
• 11.2 Baxter
  • 11.2.1 Baxter Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Baxter Fibrin Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Baxter Fibrin Products Offered
  • 11.2.5 Baxter Recent Development
• 11.3 Johnson & Johnson (Ethicon)
  • 11.3.1 Johnson & Johnson (Ethicon) Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Johnson & Johnson (Ethicon) Fibrin Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Johnson & Johnson (Ethicon) Fibrin Products Offered
  • 11.3.5 Johnson & Johnson (Ethicon) Recent Development
• 11.4 LFB Group
  • 11.4.1 LFB Group Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 LFB Group Fibrin Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 LFB Group Fibrin Products Offered
  • 11.4.5 LFB Group Recent Development
• 11.5 ProFibrix BV
  • 11.5.1 ProFibrix BV Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 ProFibrix BV Fibrin Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 ProFibrix BV Fibrin Products Offered
  • 11.5.5 ProFibrix BV Recent Development
• 11.6 Shanghai RAAS Blood Products
  • 11.6.1 Shanghai RAAS Blood Products Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Shanghai RAAS Blood Products Fibrin Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Shanghai RAAS Blood Products Fibrin Products Offered
  • 11.6.5 Shanghai RAAS Blood Products Recent Development
• 11.7 Jiangxi Boya Bio-Pharmaceutical
  • 11.7.1 Jiangxi Boya Bio-Pharmaceutical Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Jiangxi Boya Bio-Pharmaceutical Fibrin Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Jiangxi Boya Bio-Pharmaceutical Fibrin Products Offered
  • 11.7.5 Jiangxi Boya Bio-Pharmaceutical Recent Development
• 11.8 Hualan Biological Engineering
  • 11.8.1 Hualan Biological Engineering Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Hualan Biological Engineering Fibrin Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Hualan Biological Engineering Fibrin Products Offered
  • 11.8.5 Hualan Biological Engineering Recent Development
• 11.9 Harbin Pacific Biopharmaceutical
  • 11.9.1 Harbin Pacific Biopharmaceutical Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Harbin Pacific Biopharmaceutical Fibrin Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Harbin Pacific Biopharmaceutical Fibrin Products Offered
  • 11.9.5 Harbin Pacific Biopharmaceutical Recent Development
• 11.10 GREEN CROSS
  • 11.10.1 GREEN CROSS Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 GREEN CROSS Fibrin Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 GREEN CROSS Fibrin Products Offered
  • 11.10.5 GREEN CROSS Recent Development
• 11.11 Shanghai XinXing Medical

12 Future Forecast

• 12.1 Fibrin Market Forecast by Regions
  • 12.1.1 Global Fibrin Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Fibrin Revenue Forecast by Regions 2019-2025
• 12.2 Fibrin Market Forecast by Product
  • 12.2.1 Global Fibrin Sales Forecast by Product 2019-2025
  • 12.2.2 Global Fibrin Revenue Forecast by Product 2019-2025
• 12.3 Fibrin Market Forecast by End User
• 12.4 North America Fibrin Forecast
• 12.5 Europe Fibrin Forecast
• 12.6 Asia Pacific Fibrin Forecast
• 12.7 Central & South America Fibrin Forecast
• 12.8 Middle East and Africa Fibrin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Fibrin Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Fibrin market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Fibrin market based on company, product type, end user and key regions.

This report studies the global market size of Fibrin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fibrin in these regions.
This research report categorizes the global Fibrin market by top players/brands, region, type and end user. This report also studies the global Fibrin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
CSL Behring
Baxter
Johnson & Johnson (Ethicon)
LFB Group
ProFibrix BV
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical

Market size by Product
Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate
Market size by End User
Trauma patients
Cardiovascular surgery patients
PPH patients
Plastic surgery patients
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Fibrin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Fibrin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Fibrin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Fibrin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Fibrin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Fibrin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.